TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Clinical Examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of non-invasive blood pressure measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Morbidity of infection
Endpoint domain: Adverse events/effects
Primary endpoint: Change in partner violence victimization
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in reproductive coercion
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Lens Awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Best overall response (CR or CRi) in untreated AML, CMML, MDS, or MDS/MPN Overlap patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best overall response (CR or CRi) in myelofibrosis patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best overall response (CR or CRi) in relapsed/refractory AML, CMML, MDS, or MDS/MPN Overlap patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HOMA-Beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in apraxia score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Port Wine Stain response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Subjects Who Achieved FIX Level ≥12%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse Event and Adverse Drug Reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Fluorescence fundus angiography results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: Percent Change in Creatinine-adjusted Urinary N-telopeptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Antibodies against the SARS-CoV-2 virus in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rheumatoid Arthritis Pain Scale (RAPS)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Pittsburgh Insomnia Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: modification of circulating endothelial biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak increase in systolic blood pressure (delta SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area measurements of elevated RPE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of acute myocardial infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: annual average cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Memory score on ImPACT testing
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Post delivery experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IgG anti-COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IgM anti-COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IgA anti-COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency of HIV Testing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Major Pathologic Response (MPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pathologic No Response (pNR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Treatment Responder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Knowledge and Attitudes about Mental Illness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Help Seeking Behaviors
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: First Episode of Acute Respiratory Syncytial Virus-Associated Respiratory Illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change on fatigue intensity
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Abortion Success
Endpoint domain: Mortality/survival
Primary endpoint: Area under the curve for Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sleep Diary Measures
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: PSG Composite Measure
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: PSQI
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Safety/Adverse Event Outcome Measure
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Survival (OS) in the Global Population
Endpoint domain: Mortality/survival
Primary endpoint: Progression Free Survival by Independent Review Facility-Assessment (PFS-IRF)
Endpoint domain: Mortality/survival
Primary endpoint: Change in Brief Pain Inventory Short Form (BPI-sf)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Percentage of Patients Attained Blood Glucose Control Target
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tmax: Time to Reach the Maximum Plasma Concentration (Cmax) for TAK-536
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast: Area Under the Plasma Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration for TAK-536
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alterations in functional connectivity properties
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Organization of resting state networks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Perioperative and postoperative adverse cardiac and cerebrovascular events
Endpoint domain: Adverse events/effects
Primary endpoint: Surgical site infection (superficial or deep)
Endpoint domain: Adverse events/effects
Primary endpoint: Concordance of pathological lymph nodes at EUS with surgical pathology report
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Overall survival in metastatic lymph node presence
Endpoint domain: Mortality/survival
Primary endpoint: systemic inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Difference in concern scores from MYCAW questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Confirmed Abstinence From Cocaine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients on treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of patients receiving treatment information
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Standard base excess point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of reported adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of acquired images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cartilage damage thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of cigars consumed daily
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of parathyroid glands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analog scale pain level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean STAI-Part 1 post-dose score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Validity and reliability of the FIMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Daily Insulin Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in international prostate symptom score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction of Agitation on PANSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of interstitial pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: PROMIS Patient reported outcomes for physical function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: PROMIS Patient reported outcomes for pain interference
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Numerical Pain Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of individuals who complete at least 80% of offered cycling sessions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of subjects reporting an adverse event during class
Endpoint domain: Adverse events/effects
Primary endpoint: Human Papillomavirus (HPV) Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Acute ischemic stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Azithromycin absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful SWL treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiorespiratory risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in fasting insulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improved score on condom use self-efficacy scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cmax, Tmax, AUC and half-life of E5555
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thrombin- and TRAP-induced platelet aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with IOP reduction mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients with quantitative OCT variations (RNFL, μm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with quantitative VF variation (MD, dB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with quantitative VF variation (LV, dB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in glucose levels assessed via HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: changes in microvascular resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Effect Size in Subjected-Rated Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Opioid-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of the Optune NovoTTF-200A System
Endpoint domain: Adverse events/effects
Primary endpoint: Tolerability of the Optune NovoTTF-200A System
Endpoint domain: Adverse events/effects
Primary endpoint: Gut bacteriobiota diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical impact of endoscopic ultrasound treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Visual comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Productivity (correct words per hour)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: filter lifespan
Endpoint domain: Mortality/survival
Primary endpoint: Complete Response Rate (CR/CRu) at 120 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With Columbia-Suicide Severity Rating Scale (C-SSRS) Outcomes (Worst Overall Finding)
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Extrapyramidal Symptom Rating Scale (ESRS) Subscale I Total Score at Week 54
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Event-free Survival at 3 Years
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants who require a blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of Ischemia-driven TLR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of Target lesion failure TLF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Control of seated posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seated stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Compassion to others
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Self-compassion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Empathy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Psychological distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in General well-being
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pathologic complete remission (PCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major Pathologic Response (MPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of HCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in reactive hyperemia index (RHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 6-minute walk change at 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-minute walk change at one year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with TB recurrence/relapse by 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of participants with treatment failure at either 4.5 months or 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Changes in physical activity (number of steps)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-standardized meal glucose exposure (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ACR20 response in RA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of shifts with music therapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of shifts that the subject received the full 20-minute therapy uninterrupted
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient Comfort
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Participants Successfully Accrued
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fibrosis assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Steatosis assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Reduce illicit opioid use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: CT-based whole body muscle volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: CT-based whole body fat volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: absolute bioavailability of canagliflozin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Clinical Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS Leg Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum oxygen uptake (VO2peak)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under insulin degludec concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Area under liraglutide concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Probability of being free of treatment failure
Endpoint domain: Mortality/survival
Primary endpoint: Blood and urine laboratory tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vital signs and pulse oximetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of maximum concentration (tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathological response to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Decline in FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Urodynamic stress urinary incontinence measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cellulite grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Mass Index (BMI) Z-score Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mesial and distal height of extraction site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validation of small portable ultrasound units
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive and prognostic value of HE4 marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death From Cardiovascular or Renal Causes
Endpoint domain: Mortality/survival
Primary endpoint: Hospitalization for Congestive Heart Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Absence of medical complication by day 7
Endpoint domain: Adverse events/effects
Primary endpoint: Skin blood flow and cutaneous vascular conductance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Maximum-tolerated dose (MTD) of homoharringtonine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete hematologic remission (CHR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of 100% wound closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of Adverse Events (all cause)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Adverse Events causally related to Ausanil
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose of fenretinide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toxicities of fenretinide
Endpoint domain: Adverse events/effects
Primary endpoint: major complications after liver transplantation
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline Dellon Modified Moberg Pick-Up Test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rectal distension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Stability of miniscrews
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Presence of pain lasting longer than 48 hours after implantation
Endpoint domain: Adverse events/effects
Primary endpoint: Headache Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: improvement in liver stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sub-functional score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Carotenoids in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fatty acids in red blood cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total antioxidant status in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hemodynamic responses measured by BOLD signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of Rosiglitazone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of exacerbations of atopic dermatitis requiring intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Accuracy of predicted in vivo polyp histology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of INR: International Normalized Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change of aPTT: activated partial thromboplastin time (seconds)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change of MCF / EXTEM: maximum clot firmness (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Composite event rate of death, myocardial infarction, Target Vessel Revascularization or cerebrovascular event
Endpoint domain: Mortality/survival